| Q37306496 | Altered Excitatory-Inhibitory Balance in the NMDA-Hypofunction Model of Schizophrenia |
| Q34602356 | Continuous exposure to the competitive N-methyl-D: -aspartate receptor antagonist, LY235959, facilitates escalation of cocaine consumption in Sprague-Dawley rats |
| Q44999577 | Cooperation of non-effective concentration of glutamatergic system modulators and antioxidant against oxidative stress induced by quinolinic acid |
| Q28344844 | Effects of phencyclidine (PCP) and MK 801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA-, alpha(1)- and 5-HT(2A)-receptors |
| Q42905627 | Effects of postnatal dietary choline manipulation against MK-801 neurotoxicity in pre and postadolescent rats |
| Q33942431 | Environmental agents that have the potential to trigger massive apoptotic neurodegeneration in the developing brain |
| Q39412337 | Estrogens and the cognitive symptoms of schizophrenia: Possible neuroprotective mechanisms |
| Q34085206 | Gacyclidine: a new neuroprotective agent acting at the N-methyl-D-aspartate receptor |
| Q48269336 | Glutamate and GABA receptor dysfunction in the fetal alcohol syndrome |
| Q36797989 | Glutamate antagonists are neurotoxins for the developing brain |
| Q34469220 | Glutamate signaling and the fetal alcohol syndrome |
| Q30845062 | Glutamate-mediated excitotoxicity in schizophrenia: a review |
| Q34480719 | Ketamine and phencyclidine: the good, the bad and the unexpected |
| Q48760116 | Multifocal brain damage induced by phencyclidine is augmented by pilocarpine |
| Q38578480 | NMDA receptor function, memory, and brain aging |
| Q33813143 | NMDA receptor hypofunction model of schizophrenia |
| Q48327812 | NMDA-Antagonist MK-801-induced neuronal degeneration in Wistar rat brain detected by the Amino-Cupric-Silver method |
| Q46896480 | Neonatal treatment with a competitive NMDA antagonist results in response-specific disruption of conditioned fear in preweanling rats |
| Q41720705 | Ontogeny of phencyclidine and apomorphine-induced startle gating deficits in rats |
| Q48948439 | Persisting changes in brain glucose uptake following neurotoxic doses of phencyclidine which mirror the acute effects of the drug |
| Q48491745 | Phencyclidine and corticosteroids induce apoptosis of a subpopulation of striatal neurons: a neural substrate for psychosis? |
| Q42468654 | Phencyclidine induces D-1 dopamine receptor mediated Fos-like immunoreactivity in discretely localised populations of striatopallidal and striatoentopeduncular neurons in the rat. |
| Q35699016 | Potentiation of Excitotoxicity in HIV-1 Associated Dementia and the Significance of Glutaminase |
| Q36954416 | Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site |
| Q43566351 | Prenatal phencyclidine induces heightened neurodegeneration in rats in some brain regions, especially during 2nd trimester, but possible anti-apoptotic effects in others |
| Q48221355 | Short and long term changes in NMDA receptor binding in mouse brain following chronic phencyclidine treatment |
| Q61643481 | Systemic administration of the phencyclidine compound MK-801 affects stimulus-induced field potentials selectively in layer III of rat medial entorhinal cortex |
| Q51383521 | The effect of CGP-40116 on pilocarpine evoked seizures in mice exposed to transient episode of brain ischemia. |
| Q44407135 | Withdrawal from chronic phencyclidine treatment induces long-lasting depression in brain reward function |